OCT devices hold promise

Article

Improved imagery could help physicians learn more about diseases and treatment response

New optical coherence tomography (OCT) devices are in development with the goal of expanding the utility of OCT in the clinic by providing better resolution, faster speed, and software to help clinicians better understand the nuances of diseases and how they respond to therapy. Dr Jay S. Duker looked at the past, present and future of the technology during the Retina Subspeciality Day at the annual meeting of the American Academy of Ophthalmology.

The first OCTs that became commercially available in 1996 were time-domain (TD) instruments. Those reached their pinnacle in 2002 when the Stratus OCT was introduced by Zeiss. That instrument, which had 10 μm axial resolution and obtained 400 axial scans per second, remained the state-of-the-art technology until recently.

Over the past decade, many new OCT instruments have become available that are all based on Fourier-domain detection. Spectral-domain (SD) OCT became commercially available in 2006 and swept-source OCT is being used in research but is not yet commercially available. SD-OCT is faster than TD-OCT and can obtain from 20000 to 52000 scans per second. It also has a broader band width that increases the axial resolution from 4 to 7 μm.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.